Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Icahn Enterprises L.P. trades at $6.65, down about 1.5% on the week, and the dominant fact about this stock is one that has nothing to do with short sellers or options traders.
Carl Icahn is buying his own company, repeatedly and in enormous size, and the gap between where he is buying and where the units trade is widening.
His most recent acquisition, filed on September 25, brought in 40.5 million units at an average of $7.01 each. That trade alone represented roughly $284 million in fresh capital committed at prices 5% above the current quote. It was not his first. In June he added 36.5 million units at $7.30, in April a further 32.5 million at $7.67, and the pattern runs back through 2025 with similar cadence and scale. His declared stake now stands at 87.69% of the class per the amended Schedule 13D filed September 25, up from 87.28% at the prior filing. IEP carries an active 13D on the register, which by definition signals intent beyond passive accumulation. All of these trades were made outside any 10b5-1 plan, adding to their weight as signals of conviction. Icahn is buying discretionarily, at scale, consistently below $8, while the unit price has continued to drift lower.
The lending market reflects that continued skepticism from outside investors. Availability has tightened sharply this week, dropping to 15.4% from 22.1% at the start of the week. Against the 52-week tightest reading of 1.2%, that is not yet extreme, but the direction is clear: fewer shares are left in the lending pool relative to what is already borrowed. The ORTEX short score is running at 84.8, a persistently elevated level that has barely moved over the past two weeks, indicating the bearish positioning embedded in the stock is structural rather than tactical. Short interest itself is a modest 3% of the free float, so this is not a heavily shorted name in absolute terms. Borrow costs have eased considerably, down 18% on the week to 1.82%, half of where they were six weeks ago, suggesting the marginal short seller faces less friction than before even as the pool of available shares shrinks.
Options positioning has shifted markedly toward the bullish side. The put/call ratio has collapsed to 0.30, close to its 52-week low of 0.29, and well below the 20-day average of 0.33. A ratio this low means call open interest is running at roughly three times put open interest, a configuration that historically accompanies either speculative bets on a recovery or hedging activity by investors who are long the units. Given the ownership structure, the latter seems the more plausible read.
The Street is essentially absent from this name. Analyst data is well over a year stale, and the most recent coverage in the record was Jefferies maintaining a Buy with a target of $27 in August 2023, a figure that now sits at a large multiple of the current price. No firm with a current view is on record. That absence itself is notable for a publicly traded partnership with over $11 billion in enterprise value.
Retail attention has ticked up, with Wikipedia page views running 1.5 standard deviations above their 90-day baseline, though that is an attention signal rather than a financial one. The next earnings event is scheduled for November 3, and with four of the five most recent quarterly prints producing negative one-day and five-day moves, the stock's market reaction around results has been consistently soft. The August 2026 release saw a 1.3% one-day decline and a 3% five-day decline.
The tension heading into November is straightforward. Carl Icahn has committed roughly $800 million buying units below $8 over the past 18 months while the price has continued to fall, now sitting more than 6% lower than his most recent purchase price. Availability is tightening, call activity is unusually heavy relative to puts, and earnings are 26 days away. Whether those two signals, the insider's relentless accumulation and the options skew, are converging toward anything beyond positioning noise is what the November print will begin to clarify.
See the live data behind this article on ORTEX.
Open IEP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
